Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Biliary Tract Cancer”

87 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 87 results

Testing effectiveness (Phase 2)Study completedNCT01093222
What this trial is testing

Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma

Who this might be right for
Extrahepatic Bile Duct AdenocarcinomaGallbladder AdenocarcinomaGallbladder Adenocarcinoma With Squamous Metaplasia+6 more
National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT04641871
What this trial is testing

Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 78
Large-scale testing (Phase 3)Looking for participantsNCT06467357
What this trial is testing

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
AstraZeneca 620
Testing effectiveness (Phase 2)Looking for participantsNCT06778031
What this trial is testing

A Clinical Study of SHR-A1811 in the Treatment of HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer

Who this might be right for
HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 54
Testing effectiveness (Phase 2)Study completedNCT00268840
What this trial is testing

The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary Cancer

Who this might be right for
Pancreatic NeoplasmsBiliary Tract Neoplasms
ARCAGY/ GINECO GROUP 45
Testing effectiveness (Phase 2)Study completedNCT00142480
What this trial is testing

Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer

Who this might be right for
Biliary Tract CancerGallbladder Adenocarcinoma
Massachusetts General Hospital 8
Testing effectiveness (Phase 2)Looking for participantsNCT06413745
What this trial is testing

Phase II Clinical Study of SHR-A1811 in Patients With HER2 Expression / Amplification of Locally Advanced Unresectable or Recurrent Metastatic Biliary Tract Cancer

Who this might be right for
HER2 Expression / Amplification in Patients With Biliary Tract Cancer
Jiangsu HengRui Medicine Co., Ltd. 65
Early research (Phase 1)Study completedNCT00544193
What this trial is testing

Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more
City of Hope Medical Center 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT04579380
What this trial is testing

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

Who this might be right for
Uterine NeoplasmsUterine Cervical NeoplasmsBiliary Tract Neoplasms+3 more
Seagen, a wholly owned subsidiary of Pfizer 217
Early research (Phase 1)Ended earlyNCT01949870
What this trial is testing

Selumetinib (AZD6244, ARRY-142886) J-BTC Phase 1 Study

Who this might be right for
Inoperable Locally Advanced or Metastatic Biliary Tract Cancer
AstraZeneca 6
Testing effectiveness (Phase 2)Study completedNCT02631590
What this trial is testing

Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma

Who this might be right for
Biliary CarcinomaGall Bladder CarcinomaCholangiocarcinoma+1 more
H. Lee Moffitt Cancer Center and Research Institute 24
Testing effectiveness (Phase 2)Study completedNCT03531320
What this trial is testing

Study of D07001-Softgel Capsules in Subjects With Gastrointestinal Cancer in Dose-Escalation Phase and in Subjects With Biliary Tract Cancer in Dose-Expansion Phase

Who this might be right for
Gastrointestinal CancerBiliary Tract Cancer
InnoPharmax Inc. 19
Testing effectiveness (Phase 2)WithdrawnNCT02720601
What this trial is testing

Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract Cancers

Who this might be right for
Biliary Tract Cancer
New Mexico Cancer Research Alliance
Testing effectiveness (Phase 2)Looking for participantsNCT07392541
What this trial is testing

Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract Carcinoma
Tongji Hospital 29
Testing effectiveness (Phase 2)Study completedNCT00033540
What this trial is testing

S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder Cancer
SWOG Cancer Research Network 57
Testing effectiveness (Phase 2)Study completedNCT00073905
What this trial is testing

Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer+1 more
Swiss Cancer Institute 44
Testing effectiveness (Phase 2)Study completedNCT00101036
What this trial is testing

Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+5 more
National Cancer Institute (NCI) 57
Testing effectiveness (Phase 2)UnknownNCT04838964
What this trial is testing

MRG003 in the Treatment of EGFR-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer

Who this might be right for
Advanced or Metastatic Biliary Tract Cancer
Shanghai Miracogen Inc. 80
Not applicableLooking for participantsNCT06893380
What this trial is testing

Combination Therapy of GCNT and Tislelizumab in Advanced Biliary Tract Cancer

Who this might be right for
Locally Advanced Biliary Tract CancersMetastatic Biliary Tract Cancers
CHA University 61
Testing effectiveness (Phase 2)Ended earlyNCT01096745
What this trial is testing

Randomized Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary Cancer

Who this might be right for
Metastatic Biliary Tract CancerLocally Advanced Biliary Tract Cancer
Gyeongsang National University Hospital 78
Load More Results